Full-Time

Vice President

Strategy and Business Development, Urology & Critical Care, Ucc

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Medical technology for diagnostics and care

Healthcare

Senior, Expert

Monroe, GA, USA

Role is hybrid (4 days a week in Covington). Relocation assistance may be provided.

Category
Business Development
Business & Strategy
Required Skills
Marketing

You match the following Becton Dickinson's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • BA/BS degree or equivalent in business management, finance or engineering
  • Advanced degree and MBA strongly preferred
  • 15+ years of experience in strategy leadership and/or strategic innovation, preferably in the healthcare/medical device industry
  • Proven experience with converting key opinion leaders, industry leaders, and entrepreneurs’ insight into novel, profitable business opportunities
  • General Management/Business Leadership experience is a plus
  • Strong strategic thinking, business and financial acumen
  • Exceptional negotiation and influencing skills
  • Ability to maintain strong relationships with external thought leaders and market trends experts to ensure early identification of opportunity areas
  • Thorough understanding of FDA regulations within the U.S. in addition to global laws and regulations related to IP and legal implications with acquisitions of technology, products or companies
  • Strong global perspective gained through effectively working in a matrixed global environment
  • Strong external orientation focusing on customers, policy makers and regulators
  • Ability to work effectively in a team-based organization, collaborate cross-functionally; and with corporate/functions/platforms/regions
  • Organizationally savvy; proven to be pro-active in an international business environment
  • High integrity and ethics and strong fit with BD values
Responsibilities
  • Lead overall UCC strategy development, with key members of the business unit Leadership Team
  • Drive the annual strategic review process (ASR)
  • Set the operating mechanisms within the business and optimize the interface with segment
  • Lead Business Development and work with the platforms to identify and evaluate acquisition, partnership and licensing opportunities for products and technologies
  • Assess and prioritize global growth opportunities across different countries/markets and guide/partner with the regional teams to realize those opportunities
  • Advise the Business President and Senior Leadership Team (SLT) on assessing, prioritizing, and driving UCC’s long-term strategic direction and growth across its portfolio
  • Lead the process of identifying, assessing, negotiating, and finalizing new business opportunities that are in line with the overall business and strategic growth objectives for UCC and BD
  • Understand the macro-economic environment that BD UCC operates within and ensure marketing, pricing, commercial excellence, and business development strategies align with it
  • Develop a BU level marketing plan, strengthening the organization’s value propositions within and across Platforms
  • Drive commercial excellence across UCC by leveraging the BD Way of Marketing (BDWoM) and Selling (BDWoS)
  • Partner with senior leadership team members to unify and establish UCCs global pricing strategy and discipline
  • Oversee the development of the strategic annual operating plan (ASR) in conjunction with the Platforms and Regions to drive profitable growth
Desired Qualifications
  • General Management/Business Leadership experience is a plus

Becton Dickinson (BD) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on solutions for medication management and delivery; BD Life Sciences, which offers products for the safe collection and transport of diagnostic specimens; and BD Interventional, which provides devices for minimally invasive surgeries. BD generates revenue by selling medical devices, laboratory equipment, and diagnostic products. The company stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare environments.

Company Size

10,001+

Company Stage

IPO

Total Funding

$449.4K

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...